School of Medicine
Showing 51-100 of 536 Results
-
Eugene Butcher
Klaus Bensch Professor of Pathology
Current Research and Scholarly InterestsOur interests include:
-Lymphocyte migration and vascular specialization in immunity and inflammation;
-Single-cell and multi-omics dissection of vascular and immune system heterogeneity;
-AI-driven deorphanization of GPCRs and ligand discovery
-Reprogramming of vascular and immune niches in immunity and tolerance;
-Systems biology of immune cell targeting in health and disease -
M. Gohazrua K. Butler
Temp - Non-Exempt, Pathology Chair Funds
Current Role at StanfordClinical Research Coordinator Associate
Sean N. Parker Center for Allergy and Asthma Research
Department of Pathology -
Bryan James Cannon
Casual - Non-Exempt, Pathology Operations supported expenses #2
BioBryan J. Cannon is a graduate student at Stanford University, pursuing a PhD in Computational & Systems Immunology, with research focused on studying the cellular and acellular composition of human neurodegeneration using hi-dimensional imaging and sequencing datasets. He has experience in computational immunology, including multiplex ion beam imaging technology, image segmentation, and multi-dimensional analysis pipelines, as well as expertise in R, Matlab, and Python programming languages. Prior to Stanford, he worked as a Project Associate at NASA Ames Research Center and a Research Assistant at the Autoimmune & Rheumatology Lab, Bone Research Lab, and Cardiac Surgery Lab. Additionally, he has been involved in advocacy work, including mentoring high school students in summer research, working on a project for diversity and inclusion in immunology, giving lectures for the EXPLORE Lecture Series, and mentoring first-generation and low-income students at Stanford.
-
Emily Chan
Associate Professor of Pathology (Clinical Pathology)
BioDr. Chan is an Associate Professor of Pathology at Stanford University. She completed her MD, PhD at New York University and Anatomic Pathology residency with subspecialty Genitourinary Pathology training at University of California-San Francisco (UCSF). She is AP board-certified. Dr. Chan has been a GU attending at UCSF for the past five years where she has successfully mentored numerous trainees in projects, publications, and career planning. Dr. Chan has co-authored more than 40 peer-reviewed research publications and has a particular interest in integrating molecular testing in diagnostic pathology, as well as recognition of prostate cancer architectural patterns than can help with prognosis and treatment decision making.
-
Howard Y. Chang, MD, PhD
Virginia and D. K. Ludwig Professor of Cancer Research, Professor of Genetics and, by courtesy, of Pathology
On Leave from 12/16/2024 To 12/15/2026Current Research and Scholarly InterestsOur research is focused on how the activities of hundreds or even thousands of genes (gene parties) are coordinated to achieve biological meaning. We have pioneered methods to predict, dissect, and control large-scale gene regulatory programs; these methods have provided insights into human development, cancer, and aging.
-
Vivek Charu
Assistant Professor of Pathology and of Medicine (Quantitative Sciences)
BioI am a physician and a biostatistician. My clinical expertise is in the diagnosis of non-neoplastic kidney and liver disease (including transplantation). My research interests center on the design of observational studies and clinical trials, the analysis of observational data, and causal inference.
-
Greg Charville, MD, PhD
Associate Professor of Pathology
BioDr. Charville has a special interest in the diagnosis of rare tumors that derive from bone and soft tissues, including muscle, fat, blood vessels, cartilage, and other connective tissues. He also specializes in the classification and study of diseases related to the gastrointestinal and hepatopancreatobiliary systems.
Dr. Charville particularly enjoys working alongside Stanford's excellent physicians-in-training to classify the most diagnostically challenging cases in collaboration with pathologists from around the world, bringing to bear cutting-edge techniques for comprehensive histologic and molecular characterization in each case. This experience serves as the inspiration for laboratory-based investigation of the molecular underpinnings of human disease, focusing on genetic and epigenetic mechanisms of neoplasia and the translation of these mechanistic insights into novel diagnostic and predictive biomarkers. -
Michael Cleary
Lindhard Family Professor of Pediatric Cancer Biology and Professor of Pathology, Emeritus
Current Research and Scholarly InterestsThe role of oncoproteins in cancer and development; molecular and cellular biology of hematologic malignancies; targeted molecular therapies of cancer.
-
Laetitia Coassolo (Voilquin)
Senior Research Scientist - Basic Life, Pathology Sponsored Projects
Current Role at StanfordI am a Senior Research Scientist in Dr. Katrin Svensson's lab. I am interested in mapping tissue-specific peptide secretion to identify orphan peptide hormones.
-
Maria Inmaculada Cobos Sillero
Associate Professor of Pathology
Current Research and Scholarly InterestsOur lab uses cellular and molecular methods, single-cell technology, and quantitative histology to study human neurodegenerative diseases. Current projects include:
- Using single-cell RNA-sequencing to understand selective vulnerability and disease progression in human Alzheimer’s disease brain
- Investigating mechanisms of tau-related neurodegeneration in human brain
- Studying the neocortical and limbic systems in Diffuse Lewy Body Disease (DLBD) at the single cell level -
Le Cong
Assistant Professor of Pathology (Pathology Research) and of Genetics
Current Research and Scholarly InterestsOur lab develops gene-editing technologies like novel CRISPR systems and large gene insertion techniques for gene&cell therapy. We also leverages these gene-editing tools for single-cell functional screening, to probe molecular mechanisms of cancer and immunological diseases. To accelerate our work, we integrate AI and machine learning to design and evolve gene-editing proteins/RNAs in silico, pushing the frontier that bridges computational and experimental biology.
-
Joanne Cornbleet
Associate Professor of Pathology at the Stanford University Medical Center, Emerita
Current Research and Scholarly InterestsAs medical director of the Hematology Laboratory, my main focus is service work, including laboratory administration, bone marrow pathology, and flow cytometry interpretation. Publications arise primarily from development or evaluation of laboratory methods or collections of unusual patient cases.
-
Tina Cowan
Professor of Pathology (Clinical) and, by courtesy, of Pediatrics (Genetics)
Current Research and Scholarly Interestsscreening and diagnosis of patients with inborn errors of metabolism, including newborn screening, development of new testing methods and genotype/phenotype correlations.
-
Gerald Crabtree
David Korn, MD, Professor of Pathology and Professor of Developmental Biology
Current Research and Scholarly InterestsChromatin regulation and its roles in human cancer and the development of the nervous system. Engineering new methods for studying and controlling chromatin and epigenetic regulation in living cells.
-
Parnaz Daneshpajouhnejad
Affiliate, Department Funds
Fellow in PathologyBioDr. Parnaz Daneshpajouhnejad is currently completing a hematopathology fellowship at Stanford, where she also serves as a Safety Council Champion. She will be joining UCSF to advance clinical informatics initiatives, with a particular focus on digital and computational pathology.
She completed her AP/CP pathology residency at the Hospital of the University of Pennsylvania, where she served as CP Chief Resident, a College of American Pathologists (CAP) Pathology Resident Delegate, and participated in a global health rotation in South Africa and Botswana through the Penn-Botswana Partnership. During her training, she also held national leadership roles, including Secretary of the CAP Resident Forum Executive Committee.
Prior to residency, she completed a postdoctoral research fellowship in the Rosenberg Lab at Johns Hopkins School of Medicine, focusing on AI-driven analysis of renal pathology, and served on the executive board of the Johns Hopkins Postdoctoral Association.
Dr. Daneshpajouhnejad has authored over 50 journal articles and book chapters, presented at more than 20 national and international conferences, and serves as a peer reviewer for several scientific journals. During medical school, she was active in the International Federation of Medical Students’ Associations (IFMSA) and completed a pathology exchange program in Denmark. -
John W. Day, MD, PhD
Professor of Neurology and Neurological Sciences (Adult Neurology), of Pediatrics (Genetics) and, by courtesy, of Pathology
On Partial Leave from 02/25/2025 To 08/24/2025Current Research and Scholarly InterestsOur Neuromuscular Division coordinates a comprehensive effort to conquer peripheral nerve and muscle disorders, including the muscular dystrophies, motor neuron disorders, neuromuscular junction abnormalities, and peripheral neuropathies. With patients and families foremost in mind, we have had success defining and combating these diseases, with research focused on identifying genetic causes, developing novel treatment, and maximizing patient function by optimizing current management.
-
Dr. Qiwen Deng
Postdoctoral Scholar, Pathology
BioHow fibroblasts participate in the organ fibrosis and whether targeting fibroblasts is a good strategy to reverse fibrosis is still a mystery. We have identified two important immune checkpoints, CD47 and PD-L1, are highly expressed in fibroblasts and blocking CD47 and PD-L1 reversed lung fibrosis. This is a prove of concept that targeting immune regulatory pathways could be an effective therapeutic approach to treat fibrotic diseases. In addition to identifying novel targets for the treatment of fibrosis, I am also interested in the crosstalk between fibroblasts and innate immune cells in the development of fibrosis. Combined with cutting-edge NGS approaches including single cell sequencing, spatial transcriptomics and high-dimensional CyTOF technique, we have identified several potential targets and characterized immune cells landscape in lung fibrosis. In the long run, I will focus on the validation of these targets. Specifically, I will apply gain- and loss-function approaches to investigate their role in fibrosis in vitro and in vivo.
